Each year in the United States, the menopause transition is experienced by 1.5 million women. Â With this change in the hormonal milieu comes troublesome symptoms, including vasomotor symptoms, decreased libido, insomnia, changes in mood, fatigue, [...]
We have, over the last twenty years, seen many studies assessing the risks associated with prenatal exposure to antidepressants. Â For the serotonin reuptake inhibitors (SRIs), we have a fairly large body of data regarding the [...]
The article that has received the most media attention over the last few weeks is at the top of the list. Â We will be covering this in greater detail next week. In brief, this is [...]
 The title of the following article did not grab my attention; however, I discovered that this study, entitled Accuracy of the Whooley questions and the Edinburgh Postnatal Depression Scale in identifying depression and other [...]
 Serotonin reuptake inhibitor (SRI) antidepressants may affect platelet aggregation and thus may increase the risk of bleeding.  Over the last few years, we have seen several studies which have sought to determine if exposure [...]
 Following the release of the MGH Perinatal Depression Scale (MGHPDS) on the App Store this past August, we are pleased to announce that the MGHPDS is now available for Android devices on the Google [...]
 Multiple studies have demonstrated that the menopausal transition is associated with a 2- to 4-fold increased risk for clinically significant depressive symptoms. There have been several studies suggesting that hormone therapy may improve depressive [...]
This week there are two very interesting articles which look at the impact of parental exposure to adverse childhood experiences may affect a child developmental outcomes. Â Colker and colleagues note that about 20% of women [...]
 It has previously been reported that women seeking treatment at menopause clinics are more likely to report significant physical symptoms (e.g., vasomotor complaints), as well as depressive symptoms and anxiety. On the other hand, [...]
For decades, estrogen was used as a component of hormone replacement therapy to treat menopausal symptoms, including hot flashes, night sweats, and sleep disturbance; however, after several large, prospective studies (e.g., HERS, WHI) questioned the [...]
